Meeting Mic

While annual major scientific meetings are the venue to stay up-to-date in your clinical area, it is near impossible to attend all breaking news sessions. Through interviews with experts, Healio's Meeting Mic provides a post-meeting wrap-up of the most important content that listeners can consume on-the-go.

  1. 7h ago

    Highlights from ARVO 2026

    In this episode of Meeting Mic, we bring you pearls and perspectives from the Association of Vision and Research in Ophthalmology 2026. Jason Greenfield, MD, MBA, Alon Harris, MS, PhD, FARVO, and Yash Lahoti spoke with Healio about their study, which was designed to look at some of the unknown risk factors for glaucoma. 00:37 Next, Michael Zhu, a medical student at Duke University School of Medicine, told Healio about his presentation about retina imaging and how it may reveal links to Parkinson's disease. 06:12 And, Iris Fang-Yu Hu, MD, discusses her presentation on how using visual prompts helped improve glaucoma detection by a large language model. 08:35 Top headlines from the meetings. 09:31 Read the full coverage here: Glaucoma, hypertension may be linked to dementia risk Source: Greenfield J, et al. Artificial intelligence ready and exploratory atlas for diabetes insights: The association between glaucoma, hypertension, and cognitive performance. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Imaging reveals link between inner nuclear layer thickness, Parkinson's disease Source: Zhu M, et al. Macular retinal layer thickness in early Parkinson's disease. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Reference images help AI model detect glaucoma Source: Hu I, et al. Providing reference images to LLMs improves glaucoma detection from fundus photos. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Smoking may be modifiable risk factor for myopia-related vision loss Source: Flitcroft I, et al. Smoke gets in your eyes: Evidence that smoking is the first modifiable risk factor for myopia-related vision impairment. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Thyroid eye disease shows long-term progression in real-world dataset Source: Ramesh S, et al. Disease progression in thyroid eye disease: Findings from a large real-world study in the United States. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

    14 min
  2. Highlights from ASRS 2025

    08/18/2025

    Highlights from ASRS 2025

    In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 American Society of Retina Specialists annual meeting, as well as Healio's top headlines from the meeting. Andrew G. Lee, MD, discusses when retina experts should refer patients to a neuro-ophthalmologist. 0:29 Sunir J. Garg, MD, FACS, FASRS, provides an overview of lessons learned from two complex surgical cases. 1:52 Sunir J. Garg, MD, FACS, FASRS, overviewed key findings from the Global Trends in Retina Survey. 5:16 Michael O'Rouke talks collaborating with Boehringer Ingelheim to develop extended-release therapies for ophthalmic diseases. 8:17 Jay S. Duker, MD, discusses EyePoint Pharmaceuticals' second phase 3 trial of Duravyu in patients with wet age-related macular degeneration. 11:08 Read the full coverage here: https://www.healio.com/news/ophthalmology/20250731/andrew-g-lee-shares-neuroophthalmology-advice-for-retina-specialists https://www.healio.com/news/ophthalmology/20250731/sunir-garg-shares-solutions-to-complex-surgical-cases https://www.healio.com/news/ophthalmology/20250730/revana-collaborates-with-boehringer-ingelheim-to-develop-extendedrelease-therapies https://www.healio.com/news/ophthalmology/20250807/eyepoint-completes-enrollment-in-second-phase-3-trial-of-sustainedrelease-amd-therapy https://www.healio.com/news/ophthalmology/20250811/survey-treatment-for-recalcitrant-diabetic-macular-edema-varies-between-us-europe Long-term benefits seen with Gore-Tex sutures for scleral fixation of IOLs Source: Acaba-Berrocal L, et al. Long-term outcomes of pars plana vitrectomy and polytetrafluoroethylene sutured scleral-fixated intraocular lenses. Presented at: American Society of Retina Specialists annual meeting; July 30-Aug. 2, 2025; Long Beach, California. Study supports Iluvien as 'long-acting option' in diabetic macular edema Source: Singer MA, et al. NEW DAY: Study design, study sites, patient enrollment: A study of intravitreal Iluvien (fluocinolone acetonide) implant as baseline therapy in patients with early diabetic macular edema (DME) (NEW DAY). Presented at: American Society of Retina Specialists annual meeting; July 30-Aug. 2, 2025; Long Beach, California. Disclosures: Duker reports being president and CEO of EyePoint Pharmaceuticals. Garg reports no relevant financial disclosures. Lee reports no relevant financial disclosures. O'Rourke reports being CEO of Re-Vana Therapeutics.

    20 min
  3. Highlights from ASCO Annual Meeting 2025

    06/17/2025

    Highlights from ASCO Annual Meeting 2025

    In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 ASCO Annual Meeting, as well as Healio's top headlines from the meeting. Chinmay Jani, MD, discusses findings highlighting how alcohol-related cancer mortality has risen sharply over the past few decades. :19 Rachel I. Vogel, PhD, provides and overview on factors contributing to the time burden cancer care places on patients. 3:02 Alexander D. Sherry, MD, discusses how improvements in OS or quality of life after phase 3 oncology trials are based on improvements in unvalidated alternative endpoints. 4:41 Lucas A. Mavromatis, ScB, discusses findings on how GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes. 7:20 Sonali M. Smith, MD, talks with Oncology Overdrive host Shikha Jain, MD, about presentations on lymphoma at this year's ASCO meeting. 9:57 Read the full coverage here: https://www.healio.com/news/hematology-oncology/20250531/study-reveals-shocking-rise-in-alcoholrelated-cancer-deaths https://www.healio.com/news/hematology-oncology/20250603/time-burden-people-with-cancer-face-often-vastly-underestimated https://www.healio.com/news/hematology-oncology/20250604/few-phase-3-oncology-trials-demonstrate-improvements-in-os-quality-of-life https://www.healio.com/news/hematology-oncology/20250522/glp1-receptor-agonists-confer-modest-protection-against-obesityrelated-cancers https://www.healio.com/news/hematology-oncology/podcasts/oncology-overdrive/episode-119 Exercise described as 'novel, first-in-class' colon cancer therapy Source: Booth CM, et al. Abstract LBA3510. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago. At-home intervention has potential to enhance cancer care delivery, outcomes Source: Nipp RD, et al. Abstract 11003. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago. Disclosures: Jani reports no relevant financial disclosures. Mavromatis reports no relevant financial disclosures. Sherry reports honoraria from Sermo.  Smith reports no relevant financial disclosures. Vogel reports a consulting/advisory role with Voluntis.

    19 min

Ratings & Reviews

4.8
out of 5
5 Ratings

About

While annual major scientific meetings are the venue to stay up-to-date in your clinical area, it is near impossible to attend all breaking news sessions. Through interviews with experts, Healio's Meeting Mic provides a post-meeting wrap-up of the most important content that listeners can consume on-the-go.

More From Healio